- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01708109
Optimal Handling of Common Bile Duct Calculus, a Prospective Study
February 27, 2019 updated by: Anders Thorell, Karolinska Institutet
Optimal Handling of Common Bile Duct Calculus, a Prospective Randomized Study
The purpose is to study natural process of gallstones in common bile duct, stones less than or equal to 6 mm.
And if the gallstones give any complications under 1 year follow up.
The second outcome is to study side-effects of gallstones removed with surgery.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jönköping, Sweden, SE-
- Regional Hospital Ryhov
-
Linköping, Sweden, SE-581 85
- Linköping University Hospital
-
Mora, Sweden, SE-792 85
- Mora Hospital
-
Norrköping, Sweden, SE-
- Vrinnevi Hospital Norrköping
-
Stockholm, Sweden, 116 91
- Ersta sjukhus
-
Stockholm, Sweden, SE-141 86
- Karolinska university hospital
-
Stockholm, Sweden, SE-182 88
- Danderyds Hospital
-
Sundsvall, Sweden, SE-
- Sundsvalls hospital
-
Södertälje, Sweden, SE-
- Södertälje Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- cholecystectomy
Exclusion Criteria:
- Ongoing icterus or pancreatitis
- History of anamneses pancreatitis/icterus
- Allergy against x-ray contrast
- Stones more than 6 mm in ductus
- No passage of contrast to duodenum
- malignant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Biliary calculus remain
biliary calculus, less than or equal to 6 mm, remains
|
biliary calculus remain
|
|
Experimental: Biliary calculus removed
biliary calculus, less than or equal to 6 mm, removed
|
biliary calculus removed at surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Natural process of biliary calculus left after cholecystectomy
Time Frame: 12 month post op
|
Calculus in common bile duct less than or equal to 6 mm found during cholecystectomy, randomized to either remain or removed
|
12 month post op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications biliary calculus
Time Frame: 12 month post op
|
Calculus in common bile duct less than or equal to 6 mm found during cholecystectomy, randomized to either remain or removed
|
12 month post op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2011
Primary Completion (Actual)
November 20, 2017
Study Completion (Actual)
January 1, 2018
Study Registration Dates
First Submitted
October 9, 2012
First Submitted That Met QC Criteria
October 15, 2012
First Posted (Estimate)
October 16, 2012
Study Record Updates
Last Update Posted (Actual)
March 1, 2019
Last Update Submitted That Met QC Criteria
February 27, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011/873-31/3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholelithiasis
-
Mayo ClinicCompletedCHOLELITHIASISUnited States
-
Rija ZainabShaikh Zayed Hospital, LahoreRecruitingCholelithiasis Associated With Common Bile Duct StonesPakistan
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Qingdao Municipal Hospital; Qianfoshan... and other collaboratorsRecruitingCholelithiasis Associated With Common Bile Duct StonesChina
-
Nordsjaellands HospitalZealand University Hospital; Hvidovre University Hospital; Copenhagen University... and other collaboratorsRecruitingGallstones | Cholecystolithiasis | Gallstone Attack | Uncomplicated CholelithiasisDenmark
-
Myungmoon Pharma. Co. Ltd.RecruitingCholesterol CholelithiasisSouth Korea
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Qingdao Municipal Hospital; Qianfoshan... and other collaboratorsRecruitingCholelithiasis Associated With Common Bile Duct StonesChina
-
North Estonia Medical CentreCompleted
-
Ankara City Hospital BilkentCompletedCholelithiasisTurkey (Türkiye)
-
Institut National de la Santé Et de la Recherche...Active, not recruiting
-
Hospital Son EspasesUnknownCholecystitis/Cholelithiasis
Clinical Trials on no measures taken to clear bile ductus
-
Jichao QinRecruiting
-
Second Affiliated Hospital of Wenzhou Medical UniversityRecruitingAcute Respiratory Distress SyndromeChina
-
Liverpool John Moores UniversityCompletedPlacebo - Control | No Pill | CaffineUnited Kingdom
-
Chinese University of Hong KongCompletedCoronary DiseaseHong Kong